J&J’s Monarch robot wins FDA nod for AI software update

Using Nvidia and GE Healthcare technology, the robotic surgery system is intended to help doctors detect lung cancer earlier.

Among lung biopsy procedures in the U.S., robotically assisted bronchoscopy is a small but fast-growing market, where Intuitive Surgical’s Ion system also competes.

Lung cancer has one of the lowest five-year survival rates because it is often diagnosed at a late stage. If caught early, however, a patient’s chance of survival increases significantly.

Almost half of early-stage lesions are in the lung’s peripheral areas, which are hard to reach with traditional bronchoscopy, J&J said. The Monarch system is designed to help surgeons reach further into the lungs to biopsy nodules.

Sign up for Blog Updates